INTEGRILIN® (eptifibatide) Injection is currently approved for marketing in the United States.
For full Prescribing Information,
click here
(PDF) (149KB)
INTEGRILIN is a registered trademark of Millennium Pharmaceuticals, Inc.
Copyright © 2007, Schering Corporation, Kenilworth, NJ 07033
All rights reserved. ITW0007 01/07